Activity of airway antimicrobial peptides against cystic fibrosis pathogens.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Activity of airway antimicrobial peptides against cystic fibrosis pathogens.
- Published In:
- Pathogens and disease, 78(7) (2020)
- Authors:
- Cabak, Andrea, Hovold, Gisela, Petersson, Ann-Cathrine, Ramstedt, Madeleine, Påhlman, Lisa I
- Database ID:
- RPEP-04687
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04687APA
Cabak, Andrea; Hovold, Gisela; Petersson, Ann-Cathrine; Ramstedt, Madeleine; Påhlman, Lisa I. (2020). Activity of airway antimicrobial peptides against cystic fibrosis pathogens.. Pathogens and disease, 78(7). https://doi.org/10.1093/femspd/ftaa048
MLA
Cabak, Andrea, et al. "Activity of airway antimicrobial peptides against cystic fibrosis pathogens.." Pathogens and disease, 2020. https://doi.org/10.1093/femspd/ftaa048
RethinkPeptides
RethinkPeptides Research Database. "Activity of airway antimicrobial peptides against cystic fib..." RPEP-04687. Retrieved from https://rethinkpeptides.com/research/cabak-2020-activity-of-airway-antimicrobial
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.